Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Reports Development of Fetal Genetic Mutation Detection Method

NEW YORK, July 12 (GenomeWeb News) - Sequenom announced today that it has developed, in collaboration with an international consortium led by the Chinese University of Hong Kong and Boston University, a method of determining genetic mutations in circulating fetal nucleic acids in maternal plasma.

 

Using the company's MassArray technology, the researchers were able to detect the inheritance of the four most common Southeast Asian beta-thalassemia mutations in at-risk pregnancies between seven to 21 weeks of gestation, as well as analyze fetal haplotypes based on a genetic variation linked to the beta-globin locus HBB, Sequenom said.

 

Details of the development appear in the online early edition of the Proceedings of the National Academy of Sciences, the company noted.

 

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.